Roundhill GLP-1 & Weight Loss ETF
Roundhill GLP-1 & Weight Loss ETF reported 27 holdings worth US$54.1M as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 26, 2026
Roundhill GLP-1 & Weight Loss ETF reported 27 holdings worth US$54.1M as of Jun 30, 2026. Largest: Novo Nordisk A/s Class B, Eli Lilly And Company and Pfizer, Inc. Filed Aug 26, 2026 (Form N-PORT).
- Holdings
- 27
- Value as reported
- US$54.1M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Novo Nordisk A/s Class B | 148K | US$7.01M | 13.0% |
| Eli Lilly And Company | 5,722 | US$6.86M | 12.7% |
| Pfizer, Inc. | 143K | US$3.45M | 6.4% |
| Kailera Therapeutics, Inc. | 153K | US$3.36M | 6.2% |
| Viking Therapeutics, Inc. | 81,186 | US$3.17M | 5.9% |
| Cspc Pharmaceutical Group Limited | 3.24M | US$2.88M | 5.3% |
| Chugai Pharmaceutical Co., Ltd. | 52,600 | US$2.44M | 4.5% |
| Ascletis Pharma, Inc. | 1.69M | US$2.27M | 4.2% |
| Zealand Pharma A/s | 47,873 | US$2.12M | 3.9% |
| Amgen Inc. | 5,750 | US$2.08M | 3.9% |
| Astrazeneca Plc | 10,931 | US$2.07M | 3.8% |
| Hanmi Pharmaceutical Co., Ltd. | 7,386 | US$1.9M | 3.5% |
| Roche Holding Ltd | 3,972 | US$1.64M | 3.0% |
| Mbx Biosciences, Inc. | 27,421 | US$1.51M | 2.8% |
| United Laboratories International Holdings Ltd. | 1.32M | US$1.42M | 2.6% |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A | 182K | US$1.4M | 2.6% |
| Hansoh Pharmaceutical Group Company Limited | 364K | US$1.37M | 2.5% |
| Innovent Biologics, Inc. | 126K | US$1.28M | 2.4% |
| Gubra A/s | 20,597 | US$1.01M | 1.9% |
| Gilead Sciences, Inc. | 7,425 | US$938K | 1.7% |
| Rhythm Pharmaceuticals, Inc. | 7,966 | US$884K | 1.6% |
| Shionogi & Co., Ltd. | 39,100 | US$671K | 1.2% |
| Wave Life Sciences Ltd. | 80,432 | US$467K | 0.86% |
| Regeneron Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Biohaven Ltd. | 0 | US$0 | 0.00% |
| Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A | 0 | US$0 | 0.00% |
| Corbus Pharmaceuticals Holdings, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related